Boothbay Fund Management »

Iovance Biotherapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $439k 30k 14.82
2021-12-31 $708k 37k 19.09
2021-09-30 $1.1M 43k 24.67
2021-06-30 $1.2M 48k 26.03
2017-06-30 $123k 17k 7.35

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ishares Bitcoin Tr SHS
Fidelity Wise Origin Bitcoin SHS
Grayscale Bitcoin Tr Btc Shs Rep Com Ut (GBTC)
Microstrategy Cl A New Put Option (MSTR)
Bitwise Bitcoin Etf Tr Shs Ben Int
Sarepta Therapeutics Put Option (SRPT)
Spdr Ser Tr S&p Biotech Put Option (XBI)
United States Steel Corporation (X)
NVIDIA Corporation Call Option (NVDA)
Cornerstone Strategic Value (CLM)
Amazon Put Option (AMZN)
Humana Call Option (HUM)
Amphenol Corp Cl A Put Option (APH)

View all positions for Boothbay Fund Management

Top funds holding Iovance Biotherapeutics

Vanguard Group
MHR Fund Management
BlackRock
Perceptive Advisors
venBio Select Advisor
Geode Capital Management
T. Rowe Price Associates
Artisan Partners Limited Partnership
Susquehanna International
Jpmorgan Chase & Co
Goldman Sachs Group
Soleus Capital Management
Voloridge Investment Management
Pictet Asset Management Holding SA
Summit Partners Public Asset Management

View all funds holding Iovance Biotherapeutics